VeriMom¿Es salix alba/daphnoides/fragilis/purpurea bark extract seguro durante el embarazo?
No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
Related ingredients
Frequently asked questions
- ¿Es salix alba/daphnoides/fragilis/purpurea bark extract seguro durante el embarazo?
- No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
- ¿Es salix alba/daphnoides/fragilis/purpurea bark extract seguro durante la lactancia?
- No regulatory harmonised flag or authoritative safety assessment (SCCS/CIR) indicating reproductive or lactation hazards for Salix bark extracts. Theoretical transfer of small amounts of salicylates into circulation is possible from topical use, but expected to be low with typical cosmetic use; evidence for clinically relevant transfer into breast milk from cosmetic topical willow-bark is lacking.
- ¿Es salix alba/daphnoides/fragilis/purpurea bark extract seguro para la piel del bebé?
- No evidence that willow bark extract is a reproductive toxicant or teratogen in humans or animals in regulatory reviews. However, infants (0–3 yr) have higher dermal absorption per kg and a less mature barrier: if the extract contains measurable salicylates, exposure is plausibly higher (adult e=1 → infant e incremented to 2). There is limited/no infant-specific safety data for topical willow-bark-containing cosmetics.
- ¿Cómo puntúa VeriMom a salix alba/daphnoides/fragilis/purpurea bark extract?
- VeriMom puntúa salix alba/daphnoides/fragilis/purpurea bark extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a salix alba/daphnoides/fragilis/purpurea bark extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a salix alba/daphnoides/fragilis/purpurea bark extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.